Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

12.56
-1.0000-7.37%
Post-market: 12.800.2400+1.91%17:36 EST
Volume:1.18M
Turnover:14.95M
Market Cap:989.71M
PE:-3.30
High:13.76
Open:13.53
Low:12.32
Close:13.56
52wk High:18.31
52wk Low:2.21
Shares:78.80M
Float Shares:57.57M
Volume Ratio:0.86
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8010
EPS(LYR):-5.2920
ROE:-3489.00%
ROA:-31.37%
PB:-2.26
PE(LYR):-2.37

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Constellation Brands, General Motors, Ford

Reuters
·
Jan 08

Phathom Pharmaceuticals Shares Fall 13.7% Premarket After Co Announces $130 Mln Equity Raise

THOMSON REUTERS
·
Jan 08

Phathom Pharmaceuticals Inc - Shares Sold at $16.00 Each, Pre-Funded Warrants at $15.999

THOMSON REUTERS
·
Jan 08

Phathom Pharmaceuticals Inc - Announces Pricing of Public Offering of 6.87M Shares

THOMSON REUTERS
·
Jan 08

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Jan 08

Stocks to Watch: Globus Medical, L3Harris, Phathom

Dow Jones
·
Jan 08

Phathom Shares Fall on Public Offering

Dow Jones
·
Jan 08

BRIEF-Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Jan 08

BUZZ-Phathom Pharmaceuticals drops after announcing planned equity raise

Reuters
·
Jan 08

BRIEF-Phathom Pharmaceuticals Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing

Reuters
·
Jan 08

Phathom Pharmaceuticals Reports Q4 Preliminary Revenue of $$57 Million to $58 Million

MT Newswires Live
·
Jan 08

Phathom Pharmaceuticals Expects Operating Profitability in Second Half of 2026

Reuters
·
Jan 08

Phathom Pharmaceuticals Inc - Expects Q4 Net Revenues of $57-$58 Mln

THOMSON REUTERS
·
Jan 08

Press Release: Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Jan 08

Raymond James Initiates Phathom Pharmaceuticals at Strong Buy With $28 Price Target

MT Newswires Live
·
Dec 12, 2025

Barclays Initiates Phathom Pharmaceuticals at Equalweight With $16 Price Target

MT Newswires Live
·
Dec 09, 2025

Indonesia Probes 12 Legal Entities Over Forest Destruction Behind Sumatra Floods

Tempo
·
Dec 06, 2025

Phathom Pharmaceuticals (PHAT): Assessing Valuation After First Patient Dosed in VOQUEZNA EoE Phase 2 Trial

Simply Wall St.
·
Nov 13, 2025

Phathom Pharmaceuticals Inc - Topline Results Expected in 2027

THOMSON REUTERS
·
Nov 04, 2025

Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of Voquezna® (Vonoprazan) in Eosinophilic Esophagitis (Eoe)

THOMSON REUTERS
·
Nov 04, 2025